FIGURE 1—

Stages of screening process for homeless and marginally housed participants with HIV and depression for controlled trial of directly observed fluoxetine treatment.

Note. ART = antiretroviral therapy; BDI-II = Beck Depression Inventory-II; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; REACH = Research in Access to Care for the Homeless; SCID = Structured Clinical Interview for DSM-IV. Prescreening with self-report of depression; administration of 21-item BDI-II; structured clinical assessment of candidates with a BDI-II score > 13 to confirm diagnosis of major depressive disorder, minor depressive disorder, or dysthymia; and interview with study psychiatrist to confirm interest and psychiatric diagnosis, assess appropriateness of antidepressant medication treatment, and review coordination of care with potential participant’s primary care provider.